Fate Therapeutics (F6T.F) Q3 2024 Earnings

13AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.48
-0.42
-0.36
-0.3

Details

Expected EPS
-0.42149228660000004
Actual EPS
-0.30006570000000005
Surprise EPS
0.12
Surprise Percent
+28.81%

Description

Fate Therapeutics (F6T.F) has reported earnings of -0.30006570000000005 per share for Q3 2024.

0 Comments

Share your thoughts